Skip to main content
Equibles
BRKR logo

BRKR · Bruker Corp · Financials

Track BRKR — free

Use BRKR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BRKR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$53.56 -0.87 (-1.60%) At close · Sep 10
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$8.28B
Shares
155.12M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Pull these statements through the financial statements API or MCP →
Revenue
$3.44B +2.1%
FY2025 Revenue FY2009–FY2025
Net Income
-$8.6M -107.6%
FY2025 Net Income FY2009–FY2025
Gross Margin
45.91% -3.1pp
FY2025 Gross Margin FY2009–FY2025
Operating Margin
1.98% -5.5pp
FY2025 Operating Margin FY2009–FY2025
Diluted EPS
-$0.15 -119.7%
FY2025 Diluted EPS FY2009–FY2025
Operating Cash Flow
$134.1M -46.6%
FY2025 Operating Cash Flow FY2009–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2026 (G) TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010 FY2009
$3.54B – $3.57B $3.5B $3.44B $3.37BG $2.96B $2.53B $2.42B $1.99B $2.07B $1.9B $1.77B $1.61B $1.62B $1.81B $1.84B $1.79B $1.65B $1.3B $1.11B
— $1.88B $1.86B $1.72B $1.45B $1.23B $1.21B $1.05B $1.08B $995.6M $949.9M $866M $915.2M $1.05B $1.03B $962M $899.2M $700.9M $597M
— $1.62B $1.58B $1.65B $1.51B $1.31B $1.21B $939.8M $995.3M $900M $816M $745.3M $708.6M $763.3M $805.2M $829.4M $752.5M $604M $517.5M
— — 45.91% 49% 51.05% 51.59% 50.03% 47.29% 48.02% 47.48% 46.21% 46.25% 43.64% 42.2% 43.78% 46.3% 45.56% 46.29% 46.43%
— $393.5M $395.2M $376.5M $294.8M $235.9M $220.8M $198M $187.7M $173.4M $161.6M $147.9M $145.7M $174.2M $190.5M $195.3M $177.2M $141.4M $126.4M
— $970.7M $946.5M $893.8M $729.4M $607.4M $561.2M $468.6M $500.2M $444.7M $415.2M $389.8M $392.2M $451M $437.9M $440.4M $406.6M $301.1M $254M
— $128.2M $121.2M $99.1M $47.1M $37.1M $37.4M $35.8M $38.3M $28.9M $29.6M $21.7M $20.7M $20.2M $20.8M $22M $18.1M — —
— $230.1M $220.3M $183.8M $114.9M $88.8M $89.1M $80.4M $75.6M $64.9M $63.9M $54.3M $53.3M $59.7M $61.3M $59.1M $52.9M $36.1M $29.7M
— $81.9M $77.4M $24.7M $22.3M $4.8M $8.2M $15.8M $1.4M $9.4M $16.2M $20.8M $29.3M $36.1M $25.3M $500K $1M $200K $200K
— $1.66B $1.51B $1.4B $1.08B $873M $796.3M $691.5M $694.4M $637.6M $596.5M $563.5M $562.9M $657.9M $657M $673.4M $596.9M $448.3M $380.8M
— -$30.6M $68.2M $253.1M $436.9M $432.7M $413.3M $248.3M $300.9M $262.4M $219.5M $181.8M $145.7M $105.4M $148.2M $156M $155.6M $155.7M $136.7M
— — 1.98% 7.52% 14.74% 17.1% 17.09% 12.49% 14.52% 13.84% 12.43% 11.28% 8.97% 5.83% 8.06% 8.71% 9.42% 11.93% 12.27%
— $199.5M $288.5M $436.9M $551.8M $521.5M $502.4M $328.7M $376.5M $327.3M $283.4M $236.1M $199M $165.1M $209.5M $215.1M $208.5M $191.8M $166.4M
— $61.5M $60.3M $47.9M $16.4M $16.1M $14.3M $14.4M $16M $12.6M $15.4M $13.2M $13M $13.3M $13.4M $14.3M $7.3M $5.6M $7.5M
— $25.2M $14.8M $9.3M $7.5M $2.8M $900K $3.2M $1.3M $1.2M $800K $300K $1.2M $800K $1M $900K $1M $900K $1M
— $8.2M -$46.2M -$46.2M $107.3M -$18.8M -$19.7M -$22.5M -$20.5M -$17.7M -$21.7M -$4.2M -$17.7M -$4.1M -$23.6M -$17.7M -$10.1M -$5.6M $800K
— -$22.4M $22M $206.9M $544.2M $413.9M $393.6M $225.8M $280.4M $244.7M $197.8M $177.6M $128M $101.3M $124.6M $138.3M $145.5M $150.1M $129.1M
— $40.4M $29.3M $91.4M $117.7M $116.4M $113M $64.4M $82.4M $63.7M $117.5M $23.1M $23.1M $41.7M $42.8M $60.1M $51.5M $53.3M $48.1M
— -$71.2M -$8.6M $113.1M $427.2M $296.6M $277.1M $157.8M $197.2M $179.7M $78.6M $153.6M $101.6M $56.7M $80.1M $77.5M $92.3M $95.4M $81M
— — -0.25% 3.36% 14.41% 11.72% 11.46% 7.94% 9.51% 9.48% 4.45% 9.53% 6.26% 3.13% 4.35% 4.33% 5.59% 7.31% 7.27%
— $6.7M $300K $700K $1.3M $1.9M $3.5M $3.6M $800K $1.3M $1.7M $900K $3.3M $2.9M $1.7M $700K $1.7M $1.4M -$200K
— -$106.9M -$22.5M $113.1M $427.2M $296.6M $277.1M $157.8M $197.2M $179.7M $78.6M $153.6M $101.6M $56.7M $80.1M $77.5M $92.3M $95.4M $81.2M
— -$71M $15.4M $3.6M $418.4M $319.6M $267.8M $187M $154.7M $169.7M $181.5M $121.9M $29.2M -$97.5M $124.8M $72.8M $82.4M $94.3M —
USD/shares — -$0.70 -$0.15 $0.76 $2.92 $2.00 $1.83 $1.03 $1.27 $1.15 $0.50 $0.95 $0.60 $0.34 $0.48 $0.47 $0.56 $0.58 $0.50
USD/shares $2.10 – $2.15* -$0.70 -$0.15 $0.76G $2.90 $1.99 $1.81G $1.02 $1.26 $1.14 $0.49 $0.95 $0.60 $0.33 $0.48 $0.46 $0.55 $0.58 $0.49
shares — — 151.8M 149M 146.4M 148.6 151.4 153.4 155.2 156.2M 158.1M 161.4M 168.2M 167.8M 166.5M 166M 165.4M 164.4M 163.5M
shares — — 151.8M 149.5M 147.2M 149.4 152.9 154.6 156.6 157.2M 159.1M 162.2M 169.1M 169.5M 168.5M 167.4M 166.9M 165.7M 164.9M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2015–FY2025: $1.25B in buybacks, $262.3M in dividends.

Debt Profile

Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Debt data is being processed. Please check back later.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
2.83×
Peer median 2.98×
EV/EBIT
—
Peer median 22.45×
P/E (TTM)
—
Peer median 26.20×

Peer medians compare against the 37 similar-size Medical Devices companies (of 150 listed).

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Bsi Calid $1,210,200,000 $1,093,500,000 $960,400,000 $822,200,000 $819,600,000 $653,900,000 — —
BSI Nano $1,084,300,000 $1,098,300,000 $941,900,000 $787,000,000 $697,500,000 $556,100,000 $632,700,000 $568,100,000
Bsi Biospin $878,800,000 $905,700,000 $798,500,000 $696,700,000 $691,000,000 $600,000,000 — —
Energy and Supercon Technologies $263,200,000 $268,900,000 $263,700,000 $224,800,000 $223,800,000 $189,500,000 $209,900,000 $194,800,000
Bruker BioSpin Group — — — — $691,000,000 $600,000,000 $621,400,000 $591,100,000
Bruker Calid Group — — — — $819,600,000 $653,900,000 $623,500,000 $547,800,000
Bruker Nano Group — — — — $697,500,000 $556,100,000 $632,700,000 $568,100,000
Scientific Instruments Material Science — — — — — — $632,700,000 $568,100,000

By Geography (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Europe Excluding Germany $950,200,000 $873,000,000 $699,700,000 — — — — —
United States $891,300,000 $938,500,000 $777,700,000 $696,100,000 $601,000,000 $455,900,000 $529,800,000 $489,400,000
Asia Pacific Excluding China $552,600,000 $518,500,000 $460,900,000 — — — — —
China $475,800,000 $471,200,000 $528,100,000 $396,500,000 $357,600,000 $313,500,000 — —
Germany $297,000,000 $310,700,000 $281,500,000 $247,400,000 $262,600,000 $244,900,000 $213,600,000 $201,100,000
Other Country $269,600,000 $254,500,000 $216,600,000 $190,400,000 $167,100,000 $137,800,000 $173,000,000 $155,700,000
Rest of Asia Pacific — — — $408,400,000 — — — —
Rest of Europe — — — $591,900,000 $658,100,000 $519,800,000 $505,200,000 $500,200,000
Asia Pacific — — — — $371,500,000 $315,600,000 $651,000,000 $549,200,000

By Product & Service (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Product $2,766,400,000 $2,759,200,000 $2,457,600,000 $2,109,900,000 $2,017,300,000 $1,638,100,000 $1,744,700,000 $1,576,600,000
Product And Service Other $670,100,000 $607,200,000 $506,900,000 $420,800,000 $7,400,000 $6,000,000 $5,500,000 $7,300,000
Service — — — — $393,200,000 $343,400,000 $322,400,000 $311,700,000

Segment Operating Income

Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.

By Segment (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Unallocated Expenses $364,800,000 $264,900,000 $109,400,000 $72,900,000 — — — —
Bsi Calid $262,600,000 $246,200,000 $232,100,000 $216,400,000 $227,200,000 $152,200,000 — —
Bsi Biospin $156,500,000 $216,600,000 $211,200,000 $187,700,000 $158,200,000 $121,600,000 — —
BSI Nano $101,100,000 $123,900,000 $158,400,000 $138,100,000 $73,400,000 $23,600,000 $40,400,000 $48,400,000
Energy and Supercon Technologies $26,700,000 $35,100,000 $32,500,000 $30,400,000 $22,200,000 $6,200,000 $16,400,000 $14,500,000
Scientific Instruments Material Science — — — — — — $40,400,000 $48,400,000
Scientific Instruments — — — — $385,400,000 $273,800,000 $290,300,000 $244,000,000

Operating Margin by Segment (%)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Bsi Calid 21.7% 22.5% 24.2% 26.3% 27.7% 23.3% — —
BSI Nano 9.3% 11.3% 16.8% 17.5% 10.5% 4.2% 6.4% 8.5%
Bsi Biospin 17.8% 23.9% 26.4% 26.9% 22.9% 20.3% — —
Energy and Supercon Technologies 10.1% 13.1% 12.3% 13.5% 9.9% 3.3% 7.8% 7.4%
Scientific Instruments Material Science — — — — — — 6.4% 8.5%
Key facts CIK 1109354 CUSIP 116794108 13F (30d) 204 filings 203 filers Visit website Investor relations